Eurofins Scientific buys Beacon Discovery

By The Science Advisory Board staff writers

February 18, 2021 -- Bioanalytical testing firm Eurofins Scientific has purchased Beacon Discovery, a contract research organization focused on G-protein coupled receptor (GPCR) research.

Beacon has a large portfolio of validated in vitro pharmacology, "absorption, distribution, metabolism, and excretion" (collectively known as ADMET), and chemistry services for integrated drug discovery clients. The deal is expected to close in coming weeks, according to Eurofins.

The acquisition will support Eurofins' efforts to boost its drug discovery and new therapeutics offerings, it said.

Financial details of the acquisition were not disclosed.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.